查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区目标定序市场：按应用、按产品类型、靶向序列捕获方法、按目标捕获类型、按最终用户、按国家/地区 - 分析和预测 (2024-2033)
市场调查报告书
商品编码
1614806

亚太地区目标定序市场：按应用、按产品类型、靶向序列捕获方法、按目标捕获类型、按最终用户、按国家/地区 - 分析和预测 (2024-2033)

Asia-Pacific Targeted Sequencing Market: Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture, End User, and Country - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 60 Pages | 商品交期: 1-5个工作天内

价格

2023年亚太地区标靶定序市场规模为5.742亿美元。

预计2024年至2033年该市场将以14.35%的复合年增长率成长，2033年达到21.755亿美元。亚太地区标靶定序市场竞争激烈，现有企业和新兴企业在争夺市场占有率。未来几年，市场预计将持续发展和转型，机会与挑战并存，因此密切关注市场的动态和快速变化至关重要。

主要市场统计数据
预测期 2024-2033
2024年评估 6.509 亿美元
2033 年预测 21.755 亿美元
复合年增长率 14.35%

对经济实惠且高度准确的测序技术的需求不断增长、精准医学的使用不断增加以及基因组学的进步都促进了亚太地区靶向定序市场的显着增长。特定基因或感兴趣区域的标靶定序正变得越来越流行，因为它是全基因组定序的经济有效的替代方案。中国、日本、韩国和印度等国家由于强有力的政府资助、不断扩大的研究倡议和不断扩大的生物技术领域而主导了市场。

癌症和遗传性疾病等慢性疾病的增加增加了标靶定序在临床诊断和个人化治疗方法中的应用。由于次世代定序（NGS）平台的技术开拓以及学术机构和公司之间的伙伴关係不断增强，该市场正在不断扩大。此外，亚太地区人口众多，加上基于基因组学的医疗保健意识不断增强，为市场相关人员提供了巨大的商机。

此外，靶向定序因其成本效益而对临床和研究应用特别有吸引力，可以更深入地了解遗传变异，同时简化资料分析。由于基因组研究投资的增加，亚太地区标靶定序市场预计将显着成长，有助于该地区精准医学和基因组研究的进步。

该报告研究了亚太地区目标定序市场，并按应用、产品类型、靶向序列捕获方法、目标捕获类型、最终用户、国家和市场趋势提供了市场概况。

目录

执行摘要

第一章 市场

  • 趋势：当前和未来的影响评估
  • 标靶定序工作流程
  • 研究发展回顾
  • 监管状况
  • 市场动态：概述

第二章 区域

  • 区域概况
  • 促进因素和抑制因素
  • 亚太地区
    • 区域概况
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 其他的

第三章市场－竞争基准化分析与公司概况

  • 未来展望
  • 竞争格局
    • BGI Group
    • Daicel Corporation
    • Takara Bio Inc.

第四章调查方法

Product Code: BHP2457SS

Introduction to Asia-Pacific Targeted Sequencing Market

The Asia-Pacific targeted sequencing market was valued at $574.2 million in 2023 and is expected to reach $2,175.5 million by 2033, growing at a CAGR of 14.35% between 2024 and 2033. The APAC targeted sequencing market is fiercely competitive, with both established players and emerging companies vying for market share. It will be crucial to keep an eye on the market's dynamic and quickly changing landscape in the upcoming years as a result of its anticipated growth and transformation, which present both opportunities and challenges.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$650.9 Million
2033 Forecast$2,175.5 Million
CAGR14.35%

The growing demand for affordable, high-accuracy sequencing technologies, the growing use of precision medicine, and genomics advancements are all contributing to the notable growth of the APAC targeted sequencing market. Because it provides a cost-effective and efficient substitute for whole genome sequencing, targeted sequencing-which concentrates on particular genes or regions of interest-is becoming more and more popular. Thanks to strong government funding, growing research initiatives, and the expanding biotechnology sector, nations like China, Japan, South Korea, and India are dominating the market.

The use of targeted sequencing for clinical diagnostics and individualized treatment regimens has increased due to the rise in chronic diseases, such as cancer and genetic disorders. The market is growing as a result of technological developments in next-generation sequencing (NGS) platforms and growing partnerships between academic institutions and business entities. Additionally, the APAC region's large population, coupled with growing awareness about genomics-based healthcare, creates significant opportunities for market players.

Furthermore, targeted sequencing is particularly appealing for clinical and research applications due to its cost-effectiveness, which allows for deeper understanding of genetic variations while simplifying data analysis. The APAC targeted sequencing market is expected to grow significantly as genomics research investments rise, contributing to the advancement of precision medicine and genomic research in the region.

Market Segmentation

Segmentation 1: by Application

  • Cancer
  • Reproductive Health
  • Hereditary Diseases
  • Neurological Disorders
  • Infectious Diseases
  • Cardiovascular Diseases
  • Rare Diseases
  • Other Applications

Segmentation 2: by End User

  • Diagnostic and Clinical Laboratories
  • Academic and Research Institutions
  • Pharmaceutical and Biotech Companies
  • Other End Users

Segmentation 3: by Product Type

  • Instruments
  • Services
  • Kits/Panels and Assays
  • Others

Segmentation 4: by Target Enrichment Method

  • Hybridization Capture
  • Amplicon Sequencing
  • Other Target Enrichment Methods

Segmentation 5: by Target Capture

  • Targeted DNA Sequencing
  • Targeted RNA Sequencing
  • Other Types of Target Capture

Segmentation 6: by Country

  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific targeted sequencing market (by application) has been segmented into detailed segments of the application of targeted sequencing based on applications, including cancer, reproductive health, hereditary diseases, neurological disorders, infectious diseases, cardiovascular diseases, rare diseases, and other applications.

Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enable prominent players to command premium prices while maintaining growth in revenue and volume.

Competitive Strategy: Key players in the Asia-Pacific targeted sequencing market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Asia-Pacific targeted sequencing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations are expected to aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some of the prominent companies in this market are:

  • BGI Group
  • Daicel Corporation
  • Takara Bio Inc.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Increasing Number of Targeted Sequencing Products and Services in the Market
    • 1.1.2 Increasing Synergistic Partnerships between Market Players
  • 1.2 Targeted Sequencing Workflow
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Year)
  • 1.4 Regulatory Landscape
  • 1.5 Market Dynamics: Overview
    • 1.5.1 Market Drivers
      • 1.5.1.1 Increasing Demand for High Depth of Coverage in Sequencing
      • 1.5.1.2 Cost and Data Management Benefits of Targeted Sequencing as Compared to WGS
    • 1.5.2 Market Restraints
      • 1.5.2.1 Lack of Advanced Genomic Testing Centers
      • 1.5.2.2 Lack of Knowledge about New Genes
    • 1.5.3 Market Opportunities
      • 1.5.3.1 Increasing Use in Clinical Research and Trials for Better Disease Pathogenesis and/or Clinical Relevance
      • 1.5.3.2 Increasing Adoption in Targeted Therapeutics in Oncology

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Asia-Pacific
    • 2.3.1 Regional Overview
      • 2.3.1.1 Driving Factors for Market Growth
      • 2.3.1.2 Factors Challenging the Market
    • 2.3.2 Application
    • 2.3.3 Product
    • 2.3.4 China
    • 2.3.5 Application
    • 2.3.6 Product
    • 2.3.7 India
    • 2.3.8 Application
    • 2.3.9 Product
    • 2.3.10 Japan
    • 2.3.11 Application
    • 2.3.12 Product
    • 2.3.13 South Korea
    • 2.3.14 Application
    • 2.3.15 Product
    • 2.3.16 Australia
    • 2.3.17 Application
    • 2.3.18 Product
    • 2.3.19 Rest-of-Asia-Pacific
    • 2.3.20 Application
    • 2.3.21 Product

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Competitive Landscape
    • 3.2.1 BGI Group
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products
      • 3.2.1.3 Top Competitors
      • 3.2.1.4 Target Customers
      • 3.2.1.5 Key Personnel
      • 3.2.1.6 Analyst View
    • 3.2.2 Daicel Corporation
      • 3.2.2.1 Overview
      • 3.2.2.2 Top Products
      • 3.2.2.3 Top Competitors
      • 3.2.2.4 Target Customers
      • 3.2.2.5 Key Personnel
      • 3.2.2.6 Analyst View
    • 3.2.3 Takara Bio Inc.
      • 3.2.3.1 Overview
      • 3.2.3.2 Top Products
      • 3.2.3.3 Top Competitors
      • 3.2.3.4 Target Customers
      • 3.2.3.5 Key Personnel
      • 3.2.3.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Targeted Sequencing Market, $Million, 2024, 2027, and 2033
  • Figure 2: Targeted Sequencing Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 3: Asia-Pacifc Targeted Sequencing Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 4: Asia-Pacifc Targeted Sequencing Market (by Target Enrichment Method), $Million, 2023, 2027, and 2033
  • Figure 5: Asia-Pacifc Targeted Sequencing Market (by Target Capture), $Million, 2023, 2027, and 2033
  • Figure 6: Asia-Pacifc Targeted Sequencing Market (by End User), $Million, 2023, 2027, and 2033
  • Figure 7: Asia-Pacifc Targeted Sequencing Market (by Product Type), $Million, 2023, 2027, and 2033
  • Figure 8: Key Industrial Developments in Targeted Sequencing Market, 2023
  • Figure 9: Workflow of Targeted Sequencing
  • Figure 10: Targeted Sequencing Market, Number of Patents (by Country), January 2019-February 2024
  • Figure 11: Targeted Sequencing Market (by Year), January 2019-February 2024
  • Figure 12: China Targeted Sequencing Market, $Million, 2023-2033
  • Figure 13: India Targeted Sequencing Market, $Million, 2023-2033
  • Figure 14: Japan Targeted Sequencing Market, $Million, 2023-2033
  • Figure 15: South Korea Targeted Sequencing Market, $Million, 2023-2033
  • Figure 16: Australia Targeted Sequencing Market, $Million, 2023-2033
  • Figure 17: Rest-of-Asia-Pacific Targeted Sequencing Market, $Million, 2023-2033
  • Figure 18: Share of Strategic Initiatives
  • Figure 19: Data Triangulation
  • Figure 20: Top-Down and Bottom-Up Approach
  • Figure 21: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Targeted Sequencing Market, Opportunities
  • Table 3: Targeted Sequencing Market, Trend Analysis
  • Table 4: Some Product Launches in the Targeted Sequencing Market
  • Table 5: Targeted Sequencing Market, Key Partnerships and Collaborations
  • Table 6: Targeted Sequencing Market, Regulatory Landscape
  • Table 7: Impact Analysis of Market Navigating Factors, 2023-2033
  • Table 8: Comparison Between Types of Next-Generation Sequencing Techniques
  • Table 9: Targeted Sequencing Market (by Region), $Million, 2023-2033
  • Table 10: Asia-Pacific Targeted Sequencing Market (by Application), $Million, 2023-2033
  • Table 11: Asia-Pacific Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 12: Asia-Pacific Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 13: Asia-Pacific Targeted Sequencing Market (by Target Enrichment Methods), $Million, 2023-2033
  • Table 14: Asia-Pacific Targeted Sequencing Market (by Type of Target Capture), $Million, 2023-2033
  • Table 15: China Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 16: China Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 17: India Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 18: India Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 19: Japan Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 20: Japan Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 21: South Korea Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 22: South Korea Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 23: Australia Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 24: Australia Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 25: Rest-of-Asia-Pacific Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 26: Rest-of-Asia-Pacific Targeted Sequencing Market (by Product Type), $Million, 2023-2033"